drug

halneuron

1 story · latest Aug 13, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Dogwood Therapeutics Inc.

Timeline

Dogwood reports Q2 2026 results as Halneuron Phase 2b nears fall readout

Aug 13Quarterly updateDogwood Therapeutics Inc.halneuron

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.